What is Alzheimer's Disease?
Key Symptoms
What Causes Alzheimer's Disease?
Conventional Treatments
Medications
Tests and Procedures
Treatment and Prevention
How Supplements Can Help
Self-Care Remedies
Alternative Therapies
When to Call a Doctor
References
Evidence Based Rating Scale
What is Alzheimer's Disease?
Named for the German physician who first described it over a century ago, Alzheimer's disease is a progressive, degenerative, and fatal brain disorder. It is the most common form of dementia, which is a general term for the loss of memory and other intellectual abilities that interferes with daily life. Alzheimer's affects 5.3 million Americans and is the sixth leading cause of death in this country according to a 2009 report from the Alzheimer's Association. (1) In time it severely impairs memory and mental functioning, with devastating consequences for both patients and caregivers. Patients are usually over age 65 (and more likely to be in their seventies or eighties), but younger-onset Alzheimer's can occur.
The symptoms of Alzheimer's appear very slowly at first, with patients experiencing what can be mistaken for the usual forgetfulness associated with old age. Difficulty making decisions is another early symptom. As the disease progresses, however, memory loss accelerates, and patients may forget how to perform very simple tasks such as dressing and bathing. Increasingly disoriented, they tend to get lost in familiar places and fail to recognize friends and family. People with Alzheimer's often undergo personality changes, becoming hostile, anxious or withdrawn, and may display inappropriate social behavior.
In its advanced stages, the disease produces severe language impairment, loss of bowel and bladder control, and mental deterioration so great that patients become completely dependent on caregivers 24 hours a day. Alzheimer's patients die, on average, within 4-6 years of diagnosis of the disease. (2)
It is estimated that Alzheimer's affects about 13% of people over age 65. Although more women than men have Alzheimer's (16% of women and 11% of men aged 71 and older), this is probably due to the fact that women outlive men on the average and is not a gender issue.(2) The disease is neither curable nor preventable, and there are no diagnostic tests that specifically identify it. The diagnosis is made on the basis of patient history and clinical examination. Brain scans and lab tests are done to help rule out other possible causes of memory loss and dementia.
The prescription drugs tacrine, galantamine, and rivastigmine, ease symptoms to a degree in some patients with mild to moderate Alzheimer's. The FDA has approved memantine for treatment of moderate to severe symptoms and donepezil for treatment in all stages of Alzheimer's. (1) Certain supplements, particularly huperzine A, may also help improve mental functioning in the early stages of the disease. (1)
Because Alzheimer's disease, especially in its later stages, takes such a heavy toll on caregivers, anyone responsible for the care of an Alzheimer's patient should seek ways to ease the inevitable burden. Counseling, support groups, day-care services, visiting nurses and nursing homes are among the available options. (1)
Key Symptoms
The Alzheimer's Association is the primary voluntary health organization for Alzheimer's research, support, and care. They define seven stages of the disease based on symptom progression.
Stage 1—No impairment (Normal function). Individuals do not experience any memory problems nor exhibit any problems
Stage 2—Very mild cognitive decline (May be normal age-related signs or very early Alzheimer's symptoms). Individuals may sometimes forget familiar words or locations of familiar objects but show no signs to family, friends, co-workers, or health professionals.
Stage 3—Mild cognitive decline (Early-stage Alzheimer's can be diagnosed in some but not all individuals). Those close to the patient begin to notice changes in memory and concentration, which may also be measured during clinical tests and a medical interview. Symptoms in this stage include:
- Problems with name or word finding that are noticeable to family and close associates
- Decreased ability to remember people's names when introduced
- Difficulty with social and work performance which is noticeable to family and close associates
- Difficulty planning or organizing
- Inability to retain information once something has been read
Stage 4—Moderate cognitive decline (Mild or early-stage Alzheimer's). At this stage, an interview with a healthcare professional recognizes clear-cut deficiencies including:
- Inability to recall recent events or occasions
- Difficulty performing challenging mental arithmetic such as counting back from 75 by 7's
- Decreased ability to perform complex tasks such as managing finances or planning dinner for guests
- Appearing withdrawn in mentally or socially challenging situations
- Decreasing memory of personal history
Stage 5—Moderately severe cognitive decline (Moderate or mid-stage Alzheimer's). Individuals begin to experience major gaps in memory and cognitive function and require assistance with some day-to-day functions. They may experience:
- Inability to remember important details such as their phone number or address during a medical interview
- Confusion about their location, the date, or season
- Problems with easy arithmetic such as counting backwards from 20 in 2's
- No loss of memory concerning their own name or the names of spouse and children
- No need for assistance with eating or using the bathroom but may require help in choosing the proper clothing for the occasion or season
Stage 6—Severe cognitive decline (Moderately severe or mid-stage Alzheimer's). Individuals experience increased difficulty with memory and significant personality changes begin to occur. They need help with daily activities. Symptoms include:
- Loss of awareness of surroundings and most recent events
- Ability to remember their name but unable to perfectly remember personal history
- Ability to distinguish familiar faces from unfamiliar but sometimes forget name of spouse or primary caregiver
- Disruption of normal sleep/wake cycle
- Changes in temperament, characterized by anxiety, agitation, hostility, withdrawal, indifference to others, depression or displays of inappropriate social behavior
- Inability to perform such basic tasks as bathing, dressing, eating or using the bathroom without assistance.
- Loss of bowel and bladder control
- Delusions, paranoia and unfounded accusations
- Tendency to wander and become lost
Stage 7—Very severe cognitive decline (Severe or late-stage Alzheimer's). Individuals are in the final stage of the disease. They lose the ability to speak recognizably and require eating and bathroom assistance. Eventually, they acquire abnormal reflexes, they are unable to respond to their environment or control their movements, and their swallowing ability is impaired. (1)
What Causes Alzheimer's Disease?
The cause of Alzheimer's remains unknown. What is known is that the brain of Alzheimer's patients suffers a severe loss of nerve cells It is widely believed that abnormal structures in the brain known as amyloid plaques and tangles play a role in damaging nerve cells. Amyloid plaques are insoluble protein deposits that develop in the areas of the brain that control memory and other cognitive functions. However, researchers are not sure if amyloid plaques actually cause Alzheimer's or if they are by-products of the disease. Tangles are abnormally twisted protein strands that disrupt communication between neurons. This disruption leads to neuron death, which is a defining feature of Alzheimer's. Other factors that may play a role in memory loss and possibly in the development of Alzheimer's include a deficiency in certain memory-enhancing brain chemicals, decreased blood flow in the brain, a series of small strokes, cardiovascular disease, serious head injury, and slow-acting viruses. A family history of Alzheimer's may increase an individual's risk of developing the disease.
Animal studies and autopsies of human brains are providing strong evidence for a theory that Alzheimer's is a form of diabetes mellitus that selectively affects the brain. The insulin impairment seen in animal studies supports references to Alzheimer's as "type 3 diabetes mellitus." (3) In one study, treatment of Alzheimer's-induced rats with anti-diabetic drugs restored brain insulin receptor-binding. (3) A clinical study in humans showed cognitive improvement in early-stage Alzheimer's when treated with intranasal insulin. (4) A 2009 animal study concluded environmental and food exposure to nitrosamines in conjunction with a high-fat diet may promote the onset of insulin-resistant Alzheimer's neurodegeneration. (5) Some foods that contain nitrosamines include: cured meats such as bacon and lunch meats, beer, some cheeses, some fish, and non-fat dry milk. Sodium nitrite used as a preservative on the package label is a good indication that nitrosamines are likely to be present. (34)
Conventional Treatments
Since there is no cure for Alzheimer's, the primary goal of treatment is to improve functioning, decrease symptoms, and delay the progression of the disease. Delaying the onset of Alzheimer's decreases the length of time individuals have reduced quality of life and reduces healthcare costs for the disease. If onset is delayed by just one year, in ten years there would be 210,000 fewer people with the disease amounting to savings in healthcare related costs of approximately $10 billion.
Conventional treatments for Alzheimer's are based on theories about the causes of cognitive impairments. Generally, healthcare professionals divide the symptoms of the disease into two categories: cognitive and behavioral/psychiatric.
Cognitive symptoms affect an individual's memory, judgment, language, organization, and other thought processes. These symptoms are treated with prescription drugs and supplements.
Behavioral and psychiatric symptoms affect the way an individual feels and acts. Common symptoms include delusions, hallucinations, physical and verbal outbursts, restlessness, and overall emotional upset. Behavioral and psychiatric symptoms are first treated using non-drug strategies to try to minimize symptoms. For Alzheimer's patients, behavioral outbursts are often a response to environmental changes. Life events such as moving to a new residence, changing caregivers, or being asked to bathe or change clothes may increase the individual's sense of fear and confusion and lead to an unfavorable response. These responses can be minimized by:
- Creating a calm environment with minimal noise, glare, and distractions.
- Monitoring personal comfort by checking for pain, hunger, thirst, illness, and fatigue and maintaining a comfortable room temperature.
- Avoiding confrontation and arguments about facts; instead, responding to the feelings behind impossible desires or trying to redirect the patient's attention
- Being flexible, patient, and supportive.
- Providing a safe environment by using safety locks if needed. (1)
If consistent use of such approaches fails to minimize symptoms, medication may be appropriate for severe symptoms or to protect individuals from hurting themselves. A number of anxiolytic, antipsychotic, and antidepressant medications are commonly used to treat the behavioral and psychiatric symptoms of Alzheimer's. (1)
Medications
Four different types of conventional medicines are used to treat the cognitive symptoms of Alzheimer's: cholinergic agents, N-methyl-d-aspartate (NMDA) inhibitors, antioxidants, and anti-inflammatory agents.
Cholinergic agents. Typically, Alzheimer's patients have a significant deficiency of the enzyme necessary for synthesizing acetylcholine, a neurotransmitter that has been associated with the memory deficits seen in Alzheimer's. Cholinesterase inhibitors such as donepezil (Aricept), rivastigmine (Exelon), tacrine (Cognex), and galantamine (Razadyne) prevent the breakdown of acetylcholine and help to keep levels high. On average, these drugs delay progression of symptoms for 6-12 months in half of patients who take them. (6)
NMDA inhibitors. In normal cell communication, NMDA receptors are activated when they bind with the neurotransmitter glutamate. The NMDA channel opens and is receptive to receiving calcium, which is necessary for learning and memory. However, too much calcium causes excitotoxicity, which leads to the neuronal cell death seen in Alzheimer's patients. Memantine (Namenda) helps to regulate the activity of glutamate and, thus, the influx of calcium. It is the only NMDA inhibitor approved by the FDA for the treatment of Alzheimer's. Memantine delays symptoms temporarily in some patients similar to the cholinesterase inhibitors. (1, 7-8)
Antioxidants. Antioxidants protect the body against free radicals, which can damage cells. The antioxidant selegiline (Eldepryl) has been shown to improve mild cognitive impairment in Alzheimer's patients by protecting neurons. (9, 10)
Anti-inflammatory agents. The neurodegeneration of Alzheimer's is associated with the activation of microglia cells which drive inflammation and that is believed to be detrimental to neurons. Non-steroidal anti-inflammatory drugs (NSAIDs) such as ibuprofen and aspirin improve cognitive symptoms. (9, 11)
Tests and Procedures
With Alzheimer's, early diagnosis is key to having more treatment options and more time to make choices in order to maximize quality of life. If you have concerns about memory loss or other cognitive impairment for yourself or for someone close to you, the first step is to locate a doctor with whom you feel comfortable and who is well-informed about Alzheimer's. Since there is no single type of physician specializing in the diagnosis and treatment of Alzheimer's, your primary care physician may sometimes refer you to a psychiatrist, psychologist, or neurologist. (1)
There is no single test that confirms Alzheimer's. Home-screening tests for dementia should not be substituted for a thorough doctor's exam. Physicians can almost always diagnose dementia, but it may be harder to determine the exact cause. Patients should be prepared to report on:
- What symptoms have been noticed?
- When did the symptoms begin?
- How often do the symptoms occur?
- Are the symptoms worse now than when they were first noticed?
- Diet and alcohol consumption
- Use of all medications and supplements (bring a list)
The physician will also want to know about the patient's past medical history and about the medical history of family members (both living and deceased), especially those with Alzheimer's or other related disorders. (1)
In order to assess mental function, the most popular test used by physicians is the mini-mental state examination (MMSE). With this test, physicians ask a series of questions designed to test a range of everyday functions. Some of the questions include:
- State the season, day, date, year
- Given the name of three common objects, remember and repeat them in a few minutes
- Count backwards from 100 in 7's or spell a word backwards
- Give the address of this office
- Name two familiar objects in this office when pointed out
- When prompted, repeat a common phrase immediately after it was said
The maximum score on the MMSE is 30 points. A score of 20-24 indicates mild dementia, 13-20 indicates moderate dementia, and below 12 indicates severe dementia. The MMSE score in Alzheimer's patients declines about 2-4 points per year on average. (1)
Another test for mental function is the mini-cog test, which involves two steps:
- Remembering and repeating the names of three common objects within a few minutes
- Drawing a clock with all twelve numbers in the right place that represent a time specified by the examiner. (1)
During the physical exam, the physician will:
- Check vital signs and listen to the heart and lungs
- Perform a neurological exam that may include checking reflexes; coordination and balance; muscle tone and strength; eye movement; speech; and sensation (1)
- Collect blood and urine samples.
In addition to the physical tests, diagnostic imaging tests are often performed. Structural imaging tests such as magnetic resonance imaging (MRI) and computed tomography (CT) give information about the shape, position, or volume of brain tissue. Functional imaging tests such as positron emission tomography (PET) and functional MRI (fMRI) show how well brain cells are working based on how actively the cells use sugar and oxygen. (1)
Treatment and Prevention
Although strides continue to be made in the treatment of Alzheimer's symptoms, the disease cannot be cured or prevented and, after a certain point, its symptoms are irreversible. However, in the early stages of the disease, nutritional supplements may help reverse some mental impairment and perhaps even postpone the development of more severe symptoms.
Start taking supplements, singly or in combination, as soon as Alzheimer's is even suspected. It's safe to take the recommended supplements with the prescription Alzheimer's drugs tacrine and donepezil, but consult your doctor before you do so. If you have a serious medical condition or are taking medication, it is always a good idea to check with your doctor before beginning a supplement program.
How Supplements Can Help
The herb Ginkgo biloba is a key supplement in the treatment of early Alzheimer's symptoms. By increasing the blood supply to the brain, Ginkgo biloba may help improve memory in some patients. The herb also seems to have antioxidant properties, which help keep nerve cells healthy. (9, 12, 13)
A compound derived from Chinese club moss, huperzine A, has been shown in clinical studies to improve memory deficits in patients with Alzheimer's without the toxicity of tacrine. (14). Huperzine A has properties similar to approved cholinesterase inhibitors. In fact, it has better penetration of the blood-brain barrier and longer cholinesterase inhibitory action than donepezil, tacrine, and rivastigmine. (1, 14) However, Huperzine A should not be used with prescription cholinesterase inhibitors. (15)
Vinpocetine, a substance derived from the periwinkle plant, has been shown in animal studies to reduce the number of neuron deaths. (16) There is some evidence from small, short-term studies that vinpocetine improves mental functioning and memory in Alzheimer's patients. (17, 18)
In animal studies, supplementation with vitamins C and E improved cognitive behavior. (19) Low levels of these vitamins and carotenoids have been seen in Alzheimer's patients, but evidence is lacking to demonstrate that supplementation in humans prevents Alzheimer's or significantly improves cognitive symptoms. However, antioxidants improve oxidative stress, which has been linked to Alzheimer's. (20-24) Animal studies also suggest that the antioxidant properties of coenzyme Q10 may slow the progression of Alzheimer's, but human studies have not been performed in Alzheimer's patients. (25, 26)
Also take a vitamin B complex. Although not the cause of Alzheimer's disease, low levels of B vitamins have occasionally been found in patients who have Alzheimer's. Vitamin B12 and folate lower blood levels of homocysteine, elevated levels of which have been noted in Alzheimer's patients. (27) A 2009 pilot study indicated vitamin B12 may benefit patients with mild to moderate Alzheimer's; large, long-term studies are needed. (28)
Animal studies indicate the antioxidant herb gotu kola may slow the neurodegenerative effects of Alzheimer's. (29, 30) In addition, gotu kola may reduce fatigue and depression, as well as stimulate the central nervous system. Siberian ginseng may help improve memory in patients with early Alzheimer's by fostering better transmission of nerve impulses. A recent small study found Siberian ginseng improved mental functioning in the elderly after only four weeks of supplementation. (31)
Animal studies show promise with other supplements. A 2009 study showed supplementation with l-carnitine improved spatial memory retention impairment in rats. (36) A study of mice supplemented with phosphatidylserine (PS) in combination with alpha-lipoic acid, l-carnitine, glycerophosphocholine, and docosahexaenoic acid (DHA) indicated decreased oxidative stress in 57% of the mice. (37) Animal studies using carnosine indicate the supplement may prevent cell damage. (44, 45) Fish oils may help slow the cognitive decline of Alzheimer's. In animal models, specifically the DHA found in fish oil may help to protect the brain from the accumulation of beta amyloid plaques that accompany mental decline in Alzheimer's (46). In human studies, including omega-3 fatty acids as a part of an integrative treatment program slowed cognitive decline for 24 months (47). See the WholeHealthMD entries on these substances for more information.
Zinc is involved in numerous enzymatic processes related to DNA function and cell replication as well as in helping to normalize immune defects. It is known to be poorly absorbed with aging and early work suggested that it might be helpful in Alzheimer's disease. However, studies with zinc indicate the metal may have a dual role: it may initiate the formation of amyloid plaques then become involved in the mechanism of reducing the oxidative stress cause by the plaques. More studies are needed to determine if zinc supplementation is beneficial or harmful to Alzheimer's. (48) Zinc and copper have to be in balance for optimal function, and they are often supplemented together. However, in recent studies with copper supplements, the metal had no effect on the progression of Alzheimer's disease. (49)
Self-Care Remedies
Exercise regularly, although supervision may be needed if the person becomes disoriented with the surroundings. Even if it's only taking a short daily walk, exercise helps improve both mental and physical functioning. Exercises that increase blood flow to the brain and require concentration and balance such as Yoga or Tai Chi, may be even more beneficial. A dance therapy study comparing five patients with moderate Alzheimer's with five patients suffering from depression found that the AD patients actually did better in learning new waltz steps (procedural learning) than did the depressed patients. (38) Movement learning apparently happens in areas of the brain less affected by AD.
Keep the mind stimulated by reading, doing memory exercises and playing games.
Try to stay as calm and relaxed as possible. This will help minimize the agitation that interferes with concentration and may even improve memory.
Seek outside help and advice. Alzheimer's disease support groups and the Alzheimer Disease Foundation are good sources for information about caring for a person with this ailment. (1)
Since some prescription drugs can cause mental confusion, especially in older people, speak with your doctor about this issue, and ask to have all medications periodically reviewed. Medications used to treat anxiety, depression, diabetes, ulcers or Parkinson's disease are common culprits.
Alternative Therapies
Metals such as copper, zinc, iron, and aluminum have been found in the brain tissue of Alzheimer's patients and are believed to induce free radical formation. Chelation therapy targets these metals for removal from the body and may be effective in treating the neurodegenerative effects of Alzheimer's. However, some chelators have adverse effects; studies are being done to find safe and effective chelators for Alzheimer's. (32, 33)
When to Call a Doctor
Consult a doctor if you or a family member shows signs of increasing memory loss, becomes disoriented in a familiar place, or exhibits unexplained behavioral changes. (1)
References
1. Alzheimer's Association website. Available at http://www.alz.org/index.asp. Accessed January 6, 2010.
2.2009 Alzheimer's Disease Fac
|